Guarav Goyal

58PUBLICATIONS
195CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Jun 24, 2026
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

|Mar 31, 2026
Consensus recommendations for malignant histiocytic neoplasms (histiocytic, Langerhans, and interdigitating dendritic cell sarcomas).

Gaurav Goyal, Oussama Abla, John K C Chan

|Feb 09, 2026
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma.

Catherine Diefenbach, Opeyemi Jegede, Victoria Wang

|Jan 16, 2026
Clinically Suspected Neurodegeneration in Histiocytic Neoplasms as Causes of Neurologic Decline: A Retrospective Study.

Amir Barmada, Ronald S Go, John C Benson

|Aug 28, 2025
Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes.

Reema K Tawfiq, Grant M Spears, Jason R Young

|Jul 02, 2025
Symptoms, unmet needs, and quality of life in Erdheim-Chester disease: a longitudinal registry-based analysis.

Priya H Marathe, Anne S Reiner, Dana Bossert

Pageof 10

Frequent Collaborators

17 joint publications

Aishwarya Ravindran

15 joint publications

Jithma P Abeykoon

14 joint publications

Ronald S Go

12 joint publications

Mithun Vinod Shah